» Articles » PMID: 29063562

A Review of Recent Advances in Translational Bioinformatics: Bridges from Biology to Medicine

Overview
Publisher Thieme
Date 2017 Oct 25
PMID 29063562
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To highlight and provide insights into key developments in translational bioinformatics between 2014 and 2016. This review describes some of the most influential bioinformatics papers and resources that have been published between 2014 and 2016 as well as the national genome sequencing initiatives that utilize these resources to routinely embed genomic medicine into healthcare. Also discussed are some applications of the secondary use of patient data followed by a comprehensive view of the open challenges and emergent technologies. Although data generation can be performed routinely, analyses and data integration methods still require active research and standardization to improve streamlining of clinical interpretation. The secondary use of patient data has resulted in the development of novel algorithms and has enabled a refined understanding of cellular and phenotypic mechanisms. New data storage and data sharing approaches are required to enable diverse biomedical communities to contribute to genomic discovery. The translation of genomics data into actionable knowledge for use in healthcare is transforming the clinical landscape in an unprecedented way. Exciting and innovative models that bridge the gap between clinical and academic research are set to open up the field of translational bioinformatics for rapid growth in a digital era.

Citing Articles

Identification of Five N6-Methylandenosine-Related ncRNA Signatures to Predict the Overall Survival of Patients with Gastric Cancer.

Yue Q, Zhang Y, Bai J, Duan X, Wang H Dis Markers. 2022; 2022:7765900.

PMID: 35774851 PMC: 9239763. DOI: 10.1155/2022/7765900.


Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.

Fang Z, Xu S, Xie Y, Yan W World J Surg Oncol. 2021; 19(1):13.

PMID: 33441161 PMC: 7807455. DOI: 10.1186/s12957-020-02116-y.


Extensive Analysis of Gene : Discovered Five Mutations That May Cause Hereditary Spastic Paraplegia Type 3A.

Mustafa M, Murshed N, Abdelmoneim A, Abdelmageed M, Elfadol N, Makhawi A Scientifica (Cairo). 2020; 2020:8329286.

PMID: 32322428 PMC: 7140133. DOI: 10.1155/2020/8329286.


In Silico Genetics Revealing 5 Mutations in Gene Associated With Acute Myeloid Leukemia.

Mustafa M, Mohammed Z, Murshed N, Elfadol N, Abdelmoneim A, Hassan M Cancer Inform. 2019; 18:1176935119870817.

PMID: 31621694 PMC: 6777061. DOI: 10.1177/1176935119870817.


PlatformTM, a standards-based data custodianship platform for translational medicine research.

Emam I, Elyasigomari V, Matthews A, Pavlidis S, Rocca-Serra P, Guitton F Sci Data. 2019; 6(1):149.

PMID: 31409798 PMC: 6692384. DOI: 10.1038/s41597-019-0156-9.


References
1.
Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

2.
Stunnenberg H, Hirst M . The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery. Cell. 2016; 167(5):1145-1149. DOI: 10.1016/j.cell.2016.11.007. View

3.
Greninger A, Naccache S, Federman S, Yu G, Mbala P, Bres V . Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. 2015; 7:99. PMC: 4587849. DOI: 10.1186/s13073-015-0220-9. View

4.
Barrett J, Dunham I, Birney E . Using human genetics to make new medicines. Nat Rev Genet. 2015; 16(10):561-2. DOI: 10.1038/nrg3998. View

5.
Muir P, Li S, Lou S, Wang D, Spakowicz D, Salichos L . The real cost of sequencing: scaling computation to keep pace with data generation. Genome Biol. 2016; 17:53. PMC: 4806511. DOI: 10.1186/s13059-016-0917-0. View